Objective ADHD Diagnosis – Around the corner?

by Karoli on September 7, 2006 · 3 comments

Boston Life Sciences recently secured a patent for an objective diagnostic test for ADHD by measuring dopamine levels via imaging data.

In addition to methods used to objectively diagnose ADHD in adults or children, the patent covers methods that could enable physicians to determine the most effective ADHD drug treatment and/or dosage level for an individual patient, monitor the long-term progress of treatment for ADHD, and aid in identifying individuals at risk for ADHD.

Here is how they say it works, in a nutshell. A special imaging agent that binds to dopamine transporters is administered, then SPECT and PET scans are done to measure actual dopamine levels.

This is very cool news. If it works and is actually approved, it would be a wonderfully effective way to arrive at a true diagnosis, as well as squash the murmurs that ADHD is merely an invention.

Technorati Tags: , , ,

Previous post:

Next post: